Skip to main content

and
  1. No Access

    Chapter

    Use of DNA technology in the diagnosis of occult atherosclerotic disease

    Cardiovascular disease (CVD) is a major contributor to mortality in western industrialised countries [1]. Its principle cause is atherosclerosis, with clinical effects only becoming apparant after years of asy...

    Richard S. Houlston, Steve E. Humphries in Occult Atherosclerotic Disease (1991)

  2. No Access

    Chapter

    Genetics and the common cancers

    The importance of inherited predisposition is now established for a number of common cancers and the mechanisms by which mutations in some genes leads to cancer are at least partially understood. The ability t...

    Richard S. Houlston, Julian Peto in Genetic Predisposition to Cancer (1996)

  3. No Access

    Article

    Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer

    The molecular basis for most non-HNPCC familial colorectal cancer cases is unknown, but there is increasing evidence that common genetic variants may play a role. We investigated the contribution of polymorphi...

    Timothy R Porter, Frances M Richards, Richard S Houlston, D Gareth R Evans in Oncogene (2002)

  4. No Access

    Article

    The search for low-penetrance cancer susceptibility alleles

    Much of the familial aggregation of common cancer results from inherited susceptibility, but highly penetrant mutations in known genes cannot account for most of the excess. Some of the unexplained familial ri...

    Richard S Houlston, Julian Peto in Oncogene (2004)

  5. No Access

    Article

    Familial chronic lymphocytic leukemia

    The role of inherited genetic factors in the etiology of chronic lymphocytic leukemia (CLL) and other B-cell lymphoproliferative disorders is now well established. Significant familial aggregation of CLL and B...

    Richard S. Houlston, Daniel Catovsky in Current Hematologic Malignancy Reports (2008)

  6. No Access

    Chapter

    Polymorphic Variation and Risk of Colorectal Cancer

    Colorectal cancer (CRC) is the third commonest cancer worldwide after lung and breast cancer, and two-thirds of CRCs occur in developed countries [1, 2]. Despite recent advances in treatment the prognosis for CRC...

    Richard A. Hubner, Richard S. Houlston in Hereditary Colorectal Cancer (2010)

  7. Article

    Open Access

    Impact of atopy on risk of glioma: a Mendelian randomisation study

    An inverse relationship between allergies with glioma risk has been reported in several but not all epidemiological observational studies. We performed an analysis of genetic variants associated with atopy to ...

    Linden Disney-Hogg, Alex J. Cornish, Amit Sud, Philip J. Law in BMC Medicine (2018)

  8. Article

    Open Access

    Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci

    Recent genome-wide association studies of glioma have led to the discovery of single nucleotide polymorphisms (SNPs) at 25 loci influencing risk. Gliomas are heterogeneous, hence to investigate the relationshi...

    Karim Labreche, Ben Kinnersley, Giulia Berzero in Acta Neuropathologica (2018)

  9. Article

    Open Access

    Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case–control study

    The purpose of this study was to evaluate the distribution of glioma-related seizures and seizure control at the time of tumor diagnosis with respect to tumor histologic subtypes, tumor treatment and patient c...

    Shala G. Berntsson, Ryan T. Merrell, E. Susan Amirian in Journal of Neurology (2018)

  10. Article

    Open Access

    Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms

    Multiple myeloma (MM) is a biologically heterogeneous malignancy, however, the mechanisms underlying this complexity are incompletely understood. We report an analysis of the whole-genome sequencing of 765 MM ...

    Phuc H. Hoang, Sara E. Dobbins, Alex J. Cornish, Daniel Chubb, Philip J. Law in Leukemia (2018)

  11. Article

    Open Access

    Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism

    Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy. Genome-wide association studies have shown variation at 14q11.2 influences ALL risk. We sought to decipher causal variant(s) at 14q...

    James B. Studd, Minjun Yang, Zhenhua Li, Jayaram Vijayakrishnan, Yi Lu in Leukemia (2019)

  12. No Access

    Article

    Genetic predisposition for multiple myeloma

    Multiple myeloma (MM) is the second most common blood malignancy. Epidemiological family studies going back to the 1920s have provided evidence for familial aggregation, suggesting a subset of cases have an in...

    Maroulio Pertesi, Molly Went, Markus Hansson, Kari Hemminki in Leukemia (2020)

  13. Article

    Open Access

    Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

    Vallari Shah, Amy L. Sherborne, David C. Johnson, Sidra Ellis, Amy Price in Leukemia (2020)

  14. Article

    Open Access

    Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

    Structural chromosomal changes including copy number aberrations (CNAs) are a major feature of multiple myeloma (MM), however their evolution in context of modern biological therapy is not well characterized. ...

    James Croft, Sidra Ellis, Amy L. Sherborne, Kim Sharp, Amy Price in Leukemia (2021)

  15. Article

    Open Access

    The clinical utility of polygenic risk scores for chronic lymphocytic leukemia

    Amit Sud, Philip J. Law, Richard S. Houlston in Leukemia (2021)

  16. Article

    Open Access

    Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk

    Limited efforts have been made in assessing the effect of genome-wide profiling of RNA splicing-related variation on lung cancer risk. In the present study, we first identified RNA splicing-related genetic var...

    Wenjun Yang, Hongliang Liu, Ruoxin Zhang, Jennifer A. Freedman in npj Precision Oncology (2022)

  17. Article

    Open Access

    Genetic landscape of interval and screen detected breast cancer

    Interval breast cancers (IBCs) are cancers diagnosed between screening episodes. Understanding the biological differences between IBCs and screen-detected breast-cancers (SDBCs) has the potential to improve ma...

    Charlie Mills, Amit Sud, Andrew Everall, Daniel Chubb in npj Precision Oncology (2024)